ANDROGEN DEPENDENT ANGIOGENESIS IN THE PROSTATE
$233,341R01FY2000DKNIH
New York University School Of Medicine, New York NY
Investigators
Linked publications & trials
Paper 18361413Paper 17440972Paper 17221843Paper 17143873Paper 15899981Paper 12082083Paper 11816016Paper 11027487
Abstract
DESCRIPTION (Adapted from the Applicant's Abstract): In this second revised submission, the applicant details studies to examine mechanisms regulating vascularization of the normal prostate. Based on consideration that: (a) prostatic vascularity is androgen modulated, and (b) endothelial cells lack androgen receptors, the applicant proposes that androgen-mediated prostatic angiogenesis is indirectly effected by the potent angiogenic factor, vascular endothelial growth factor (VEGF). It is believed that expression of VEGF is androgen-modulated in non-endothelial prostatic cells.
View original record on NIH RePORTER →